Type 2 innate immunity promotes the development of pulmonary fibrosis in Hermansky-Pudlak syndrome is a research paper published in JCI Insight (2024). On theSindex it has a DataRank of 0.511. It has been cited 13 times, with 13 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0.115
From 8 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 13 citers.
National Heart, Lung, and Blood Institute
Grant: R01 HL146498
National Institute of General Medical Sciences
Grant: P20 GM103652
National Institute of General Medical Sciences
Grant: U54 GM115677
National Heart, Lung, and Blood Institute
Grant: T32 HL134625
American Thoracic Society
Grant: 23-24PHP11
American Heart Association
Grant: 24TPA1277918
National Human Genome Research Institute
Grant: Intramural Research Program
NHLBI NIH HHS
Grant: R25 HL088992
National Institutes of Health
Grant: 5T32HL134625-03
Brown Respiratory Research Training Program
National Institutes of Health
Grant: 3U54GM115677-05S1
Rhode Island Center for Clinical and Translational Science
National Institutes of Health
Grant: 5R01HL146498-02
Targeting CHI3L1 and its receptors in Hermansky-Pudlak Syndrome-associated lung disease
National Institutes of Health
Grant: 1P20GM103652-01A1
Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction
Intramural NIH HHS
FWCI
2.96
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords